Colinz Laboratories share news, announcements and annual reports
BSE: 531210Pharmaceuticals & BiotechnologySmall Cap
Colinz Laboratories ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1995
Last close ₹69.25down ₹0.75 (1.07%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹70.00.
30 Oct: open ₹72.39, high ₹72.39, low ₹67.50
52-week range of traded prices to 30 Oct 2026
₹36.11Low, 13 Nov 2025₹87.91High, 30 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17 Cr4,457th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.27
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 908.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,008
Colinz Laboratories board meetings
114 filed, newest first. Page 2 of 3.
Aug 2023
Jul 2023
14 Jul · Board meeting
Meeting on 31 Jul 2023: quarterly results
May 2023
3 May · Board meeting
Meeting on 27 May 2023: audited results
Jan 2023
12 Jan · Board meeting
Meeting on 28 Jan 2023: quarterly results
Oct 2022
17 Oct · Board meeting
Meeting on 31 Oct 2022: quarterly results
Jul 2022
14 Jul · Board meeting
Meeting on 30 Jul 2022: quarterly results
May 2022
16 May · Board meeting
Meeting on 28 May 2022: audited results and quarterly results
Apr 2022
1 Apr · Board meeting
Meeting on 15 Apr 2022
Feb 2022
18 Feb · Board meeting
Meeting on 28 Feb 2022
Jan 2022
12 Jan · Board meeting
Meeting on 31 Jan 2022: quarterly results
Oct 2021
14 Oct · Board meeting
Meeting on 30 Oct 2021: quarterly results
Jul 2021
14 Jul · Board meeting
Meeting on 30 Jul 2021: quarterly results
May 2021
7 May · Board meeting
Meeting on 27 May 2021: quarterly results
Jan 2021
12 Jan · Board meeting
Meeting on 30 Jan 2021: quarterly results
Oct 2020
15 Oct · Board meeting
Meeting on 31 Oct 2020: quarterly results
Aug 2020
5 Aug · Board meeting
Meeting on 14 Aug 2020: quarterly results
Jun 2020
17 Jun · Board meeting
Meeting on 30 Jun 2020: quarterly results
Jan 2020
14 Jan · Board meeting
Meeting on 31 Jan 2020: quarterly results
Oct 2019
9 Oct · Board meeting
Meeting on 31 Oct 2019: quarterly results